Recent Finacing
Recent Raise
Seed Therapeutics is a biotech company developing rationally designed molecular glue degraders, led by its RBM39-targeting candidate ST-01156.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Seed Therapeutics.
